Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 02, 2022
Syner-G BioPharma Group announced the acquisition of Impact Pharmaceutical Services. Based in Research Triangle Park, NC, IMPACT supports the outsourced medical writing, regulatory strategy, and regulatory publishing and submission needs of biotech ...
read more
Symbiosis has signed a supply agreement with AstraZeneca for sterile manufacture of the COVID-19 recombinant adenovirus vaccine known as AZD1222.
read more
Friday, September 28, 2018
Symbiosis Pharmaceutical Services has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK.
read more
Symbiosis Pharmaceutical Services has secured £1million of finance from Allied Irish Bank (GB) to support its 2020 growth strategy.
read more
Tuesday, December 17, 2019
Contract Manufacturing Organization (CMO) Symbiosis Pharmaceutical Services has expanded its sterile biologics manufacturing facility in Scotland, UK by 25%.
read more
Wednesday, January 19, 2022
In a broad career, Dr Woler has held multiple key roles in the sector, including CEO at Roche France, Executive Chairman for Europe at SmithKline Beecham PLC, and CEO at Cadus Pharmaceutical in the US.
read more
Sygnature Discovery announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. The new service line expands the company’s portfolio into formal preclinical drug development. A new world-class facility with ...
read more
SwiftScale Biologics has successfully manufactured a COVID-19 neutralizing antibody candidate at clinical scale.
read more
Friday, December 07, 2012
Suzhou Pharma Services, a contract development and manufacturing organization has received the latest 2010 cGMP certification from the Chinese SFDA for their development and manufacturing facility located in the Suzhou Industrial Park, Suzhou, China....
read more
Suzhou Pharma Services www.suzhoupharma.com , an affiliate of Amerigen Pharmaceuticals, a new contract development and manufacturing organization specializing in solid oral dosage forms, is proud to announce the location of our new corporate ...
read more
Wednesday, December 30, 2020
SAI is voluntarily recalling Paroex Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 12/31/2020 – 9/30/2022 to the consumer level.
read more
Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab.
read more
Wednesday, February 26, 2020
Sun Pharmaceutical has launched Riomet ER™ in the U.S. to improve glycemic control in patients 10 years of age and older with type 2 diabetes mellitus.
read more
Wednesday, March 13, 2019
SGS welcomed the preliminary data from a controlled human infection trial with FluGen’s investigational M2SR vaccine.
read more
Wednesday, February 11, 2015
Dishman Group has announced the successful completion of an inspection by the U.S. Food and Drug Administration (FDA) for its Netherlands site. The inspection, carried out by an USFDA investigator, was planned for 5 days but lasted 3 days, starting ...
read more